439 related articles for article (PubMed ID: 27626176)
1. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
Fartoux L; Rosmorduc O
Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
[TBL] [Abstract][Full Text] [Related]
3. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
Zhu J; Yin T; Xu Y; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
[TBL] [Abstract][Full Text] [Related]
4. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
5. Newer treatments for advanced hepatocellular carcinoma.
Song MJ; Bae SH
Korean J Intern Med; 2014 Mar; 29(2):149-55. PubMed ID: 24648795
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy].
Parisod L; Duran R; Denys A; Digklia A
Rev Med Suisse; 2017 May; 13(563):1032-1034. PubMed ID: 28636293
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
Yoon HI; Seong J
Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
[TBL] [Abstract][Full Text] [Related]
9. Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond.
Kudo M
World J Gastroenterol; 2019 Feb; 25(7):789-807. PubMed ID: 30809080
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatocellular carcinoma.
Giuliani F; Colucci G
Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
[TBL] [Abstract][Full Text] [Related]
11. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Shimose S; Iwamoto H; Tanaka M; Niizeki T; Shirono T; Kajiwara A; Noda Y; Kamachi N; Okamura S; Nakano M; Kuromatsu R; Kawaguchi T; Koga H; Torimura T
Oncology; 2021; 99(12):756-765. PubMed ID: 34518483
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies.
da Motta Girardi D; Correa TS; Crosara Teixeira M; Dos Santos Fernandes G
J Gastrointest Cancer; 2018 Sep; 49(3):227-236. PubMed ID: 29806062
[TBL] [Abstract][Full Text] [Related]
13. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
14. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
Au JS; Frenette CT
Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
Raza A; Sood GK
World J Gastroenterol; 2014 Apr; 20(15):4115-27. PubMed ID: 24764650
[TBL] [Abstract][Full Text] [Related]
16. Advances in non-surgical management of primary liver cancer.
Chen X; Liu HP; Li M; Qiao L
World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
[TBL] [Abstract][Full Text] [Related]
17. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
[TBL] [Abstract][Full Text] [Related]
18. [Evidence and topics of chemotherapy for hepatocellular carcinoma].
Ueshima K; Kudo M
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1621-1628. PubMed ID: 28883291
[No Abstract] [Full Text] [Related]
19. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
Chang Lee R; Tebbutt N
Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
[TBL] [Abstract][Full Text] [Related]
20. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma].
Zhou HB; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
